JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Application Notes
Investigating GPCR contribution to anti- and pro-fibrotic signaling with HT...
Three drug discovery approaches for Multiple Sclerosis
PROTAC assays design at-a-glance
Neutralizing antibodies in Autoimmunity
Bioassays used to characterize viral particles for gene therapy discovery a...
Review of cell-based methods to monitor CAR-T activation and cell killing e...
Inhibition of FGFR Signaling Pathways Studied in Cancer Cell Lines Using HT...
HTRF analysis and imaging of phospho-S65-ubiquitin in cellular models of mi...
Improve PROTAC Targeting Kinase Discovery
A new specific kit for characterizing compounds inducing B-arrestin2 recrui...
GPCR compounds identification and pharmacological characterization with GTP...
KRAS GTP competitors and KRAS/SOS1 inhibitors screening with new HTRF bioch...
Upstream/Downstream GPCR Readout Monitoring with GTP Gi Binding and cAMP Gi...
Highly specific tools for β arrestin monitoring in various cells
Pharmacological validation of a panel of GPCRs with the HTRF GTP Gi Binding...
Detection of MAPK activation to evaluate the efficacy and potency of KRAS /...
Neuroinflammation Research Solutions with HTRF Assays
Overcoming challenges for treating solid tumors
Cell Signaling Pathways in Autoimmune Diseases and Inflammation Disorders w...
Signaling pathways in liquid tumors
Une nouvelle version du kit ELISA CISBIO Chromogranine A (# : CGA-ELISA-NG)
A new version of CISBIO Chromogranin A ELISA kit (#: CGA-ELISA-NG)
Methodological Aspects of Homogeneous Time-Resolved Fluorescence (HTRF)
Cyclic-AMP: A Functional Second Messenger for Assaying GPCR Target Activati...
Cardiovascular Research With HTRF Assays
Assessment of drug efficacy and toxicity by combining innovative technologi...
Streamline the CHO HCP impurity quantification workflow with new high throu...
AAV Capsid Detection and Characterization with Alphalisa Assay Kits
Combining Kinetic Ligand Binding and 3D Tumor Invasion Technologies to Asse...
Uncover the Full Potential of PROTAC®s with a No-Wash HTRF Platform
